Involvement of NO, H2O2 and TNF-α in the reduced antitumor activity of murine peritoneal macrophages by aflatoxin B1

Cancer Letters

Volumn 136, Issue 2, 1999, Pages 167-176

  Moon, Eun Yi ^a   Rhee, Dong Kwon ^b   Pyo, Suhkneung ^b  

^a DongWha Pharm Ind Co   (South Korea)

^b Sungkyunkwan University   (South Korea)

Author keywords

Aflatoxin B1 (AFB1); LPS; Macrophages; NO; TNF

Indexed keywords

AFLATOXIN B1; CATALASE; HYDROGEN PEROXIDE; LIPOPOLYSACCHARIDE; N(G) METHYLARGININE; NITRIC OXIDE; PEROXIDASE; SUPEROXIDE DISMUTASE; TUMOR NECROSIS FACTOR ALPHA; ANTIBODY; ENZYME INHIBITOR; INDUCIBLE NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE; NOS2 PROTEIN, MOUSE; NOS2A PROTEIN, HUMAN; SCAVENGER;

ANIMAL CELL; ANTINEOPLASTIC ACTIVITY; ARTICLE; CELL ACTIVATION; COCULTURE; CONTROLLED STUDY; DOSE RESPONSE; HOST RESISTANCE; MOUSE; NONHUMAN; PERITONEUM MACROPHAGE; PRIORITY JOURNAL; TUMOR CELL LINE; ANIMAL; CELL CULTURE; CELLULAR IMMUNITY; CYTOTOXICITY TEST; DRUG ANTAGONISM; DRUG EFFECT; HUMAN; IMMUNOLOGY; MACROPHAGE ACTIVATION; METABOLISM; PHYSIOLOGY;

MURINAE;

AFLATOXIN B1; ANIMALS; ANTIBODIES; CYTOTOXICITY TESTS, IMMUNOLOGIC; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME INHIBITORS; FREE RADICAL SCAVENGERS; HUMANS; HYDROGEN PEROXIDE; IMMUNITY, CELLULAR; MACROPHAGE ACTIVATION; MACROPHAGES, PERITONEAL; MICE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE II; OMEGA-N-METHYLARGININE; TUMOR CELLS, CULTURED; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0032587275     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3835(98)00320-6     Document Type: Article

References (40)

1. Robens J.F., Richard J.L. Aflatoxins in animal and human health. Rev. Environ. Contam. Toxicol. 127:1992;69-94.
2. Corrier D.E. Mycotoxicosis: Mechanisms of immunosuppression. Vet. Immunol. Immunopathol. 30:1991;73-87.
3. 1. Toxicology. 43:1987;123-132.
4. 1 on murine lymphocytic functions. Toxicology. 54:1989;31-44.
5. 1 and bovine lymphocytes. J. Dairy Sci. 67:1984;110-114.
6. Paul P.S., Johnson D.W., Mirocha C.J., Soper B.S. In vitro stimulation of phytomitogen and specific antigen lymphocyte responses by aflatoxin. Am. J. Vet. Res. 38:1977;2033-2035.
7. Cysewski S.J., Wood R.L., Pier A.C., Baetz A.L. Effects of aflatoxin on the development of acquired immunity to swine erysipelas. Am. J. Vet. Res. 39:1978;445-448.
8. 1 upon phytohemagglutinin-transformed human lymphocytes. Proc. Soc. Exp. Biol. Med. 134:1970;112-115.
9. 1 and T-2 toxin on the granulocyte-macrophage progenitor cells in mouse bone marrow cultures. Immunopharmacology. 27:1994;57-65.
10. Jakab G.J., Hmieleski R.R., Zarba A., Hemenway D.R., Groopman J.D. Respiratory flatoxicosis: Suppression of pulmonary and systemic host defense in rats and mice. Toxicol. Appl. Pharmacol. 125:1994;198-205.
11. Richard J.L., Thurston J.R., Pier A.C. Effects of mycotoxins on immunity. Rosenberg P. Toxins and Plant and Microbial. 1978;801 Pergamon Press, Oxford.
12. 1. J. Appl. Pharmacol. (Korea). 4:1996;190-195.
13. Raisuddin S., Zaidi S.I.A., Singh K.P., Ray P.K. Effect of subchronic aflatoxin exposure on growth and progression of Ehrlich's ascites tumor. Drug Chem. Toxicol. 14:1991;185-206.
14. Adams D.O., Hamilton T.A. The cell biology of macrophage activation. Annu. Rev. Immunol. 2:1984;283-318.
15. Nathan C.F. Secretory products of macrophages. J. Clin. Invest. 79:1987;319-326.
16. Schmidt H.H.W., Lohmann S.M., Walter U. The nitric oxide and cyclic GMP signal transduction system: Regulation and mechanism of action. Biochim. Biophys. Acta. 1178:1993;153-175.
17. Clark R.A., Klebanoff S.J. Neutrophil-mediated tumor cell cytotoxicity: Role of the peroxidase system. J. Exp. Med. 141:1975;1442-1447.
18. Carswell E.A., Old L.J., Kassel R.L., Green S., Fiore N., Williamson B. An endotoxin-induced serum factor that causes necrosis of tumors. Proc. Natl. Acad. Sci. USA. 72:1975;3666-3670.
19. Lancaster J.R.Jr., Hibbs J.B. Jr. EPR demonstration of iron-nitrosyl complex formation by cytotoxic activated macrophages. Proc. Natl. Acad. Sci. USA. 87:1990;1223-1227.
20. Stuehr D.J., Marletta M.A. Mammalian nitrate biosynthesis: Mouse macrophages produce nitrite and nitrate in response to Escherichia coli lipopolysaccharide. Proc. Natl. Acad. Sci. USA. 82:1985;7738-7742.
21. Higuchi M., Higashi N., Taki H., Osawa T. Tumor necrosis factor and L-arginine-dependent mechanisms act synergistically as the major cytolytic mechanisms of activated macrophages. J. Immunol. 144:1990;1425-1431.
22. Klostergaard J., Leroux M.E., Hung M. Cellular models of macrophage tumoricidal effector mechanisms in vitro. J. Immunol. 147:1991;2802-2808.
23. Pyo S., Gangemi J. D., Ghaffar A., Mayer E. P. Poly I:C-induced anti-herpes simplex virus type I activity in inflammatory macrophages is mediated by induction of interferon-β J. Leukocyte Biol. 50:1991;479-487.
24. Klimetzek V., Remold H.G. The murine bone marrow macrophage, a sensitive indicator cell for murine migration inhibitory factor and a new method for their harvest. Cell. Immunol. 53:1980;257-265.
25. Carmichael J., DeGraff W.G., Gazdar A.F., Minna J.D., Mitchell J.B. Evaluation of a tetrazolium-based semiautomated colorimetric assay: Assessment of chemosensitivity testing. Cancer Res. 47:1987;936-942.
26. Ding A.H., Nathan C.F., Stuehr D.J. Release of reactive nitrogen intermediates and reactive oxygen intermediates from mouse peritoneal macrophages: Comparison of activating cytokines and evidence for independent production. J. Immunol. 141:1988;2407-2412.
27. Flick D.A., Gifford G.E. Comparison of in vitro cell cytotoxicity assays for tumor necrosis factor. J. Immunol. 68:1984;167-175.
28. Klostergaard J. A rapid extremely sensitive, quantitative microassay for cytotoxicity cytokines. Lymphokine Res. 4:1985;309-317.
29. Stossel T.P. Evaluation of opsonic and leukocyte function with a spectrophotometric test in patients with infection and with phagocytic disorder. Blood. 42:1973;121-130.
30. Campbell T.C., Stoloff L. Implication of mycotoxins for human health. J. Agric. Food Chem. 22:1974;1006-1015.
31. McLean M., Dutton M.F. Cellular interactions and metabolism of aflatoxin: An update. Pharmacol. Ther. 65:1995;163-192.
32. 1 on interleukin-1 production in bovine macrophages. Drug Dev. Res. 24:1991;157-166.
33. 1. Cancer Res. 35:1975;3811-3823.
34. 1-induced hepatocellular carcinoma and adenoma in the rat: Detection by denaturing gradient gel electrophoresis. Proc. Natl. Acad. Sci. USA. 90:1993;2045-2049.
35. Nose H., Imazeki F., Ohto M., Omata M. p53 Gene mutation and 17p allelic deletion in hepatocellular carcinoma from Japan. Cancer. 72:1993;355-360.
36. 1exposure: Phosphatidylinositol metabolism. Chem.-Biol. Interact. 98:1995;145-152.
37. Tobias P.S., Soldau K., Kline L., Lee J.D., Kato K., Martin T.P., Ulevitch R.J. Cross-linking of lipopolysaccharide (LPS) to CD14 on THP-1 cells mediated by LPS-binding protein. J. Immunol. 150:1993;3011-3021.
38. Landmann R., Scherer F., Schumann R., Link S., Sansano S., Zimmerli W. LPS directly induces oxygen radical production in human monocytes via LPS binding protein and CD14. J. Leukocyte Biol. 57:1995;440-449.
39. North R.J. The concept of the activated macrophages. J. Immunol. 121:1978;806-809.
40. Sharma S.D., Remington J.S. Macrophage activation and resistance to intracellular infection. Lymphokines. 3:1981;181-212.